Article Figures & Data
Figures
- Figure 1.
Overall survival curves of patients with unresectable multiple CRLM according to the induction of conversion surgery.
- Figure 2.
Overall survival curves of patients with unresectable multiple CRLM according to the induction of conversion surgery, who received FOLFOXIRI or other regimens.
- Figure 3.
Representative cases of sinusoidal obstructive syndrome according to molecular agent. A: Surgical specimen of non-tumour tissue after nine courses of FOLFOXIRI with an anti-EGFR agent. B: Surgical specimen of non-tumour tissue of eight courses of FOLFOXIRI with an anti-VEGF agent.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery
- Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer
- A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer